Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Folia Biol (Praha) ; 61(4): 147-55, 2015.
Article in English | MEDLINE | ID: mdl-26441204

ABSTRACT

The aim of our study was to determine the effect of potential anti-tumour agent benfluron on human leukemic cells MOLT-4 and elucidate the molecular mechanisms of response of tumour cells to this chemotherapeutic agent. It has been shown that the mechanisms of action of benfluron are complex, but the molecular pathways of the cytostatic effect have remained unknown and the present study contributes to their elucidation. In this work, benfluron reduced viability of the treated cells and induced caspase-mediated apoptosis. The programmed cell death was associated with activation of caspases 8, 9 and 3/7. Moreover, exposure of cells to benfluron resulted in accumulation of the cells primarily in late S and G2/M phases. The changes in the levels of key proteins show that benfluron provoked activation of p53 and induced phosphorylation of p53 on serine 15 and serine 392. The application of benfluron led to phosphorylation of Chk1 on serine 345 and phosphorylation of Chk2 on threonine 68 in the treated cells. Higher doses of benfluron caused phosphorylation of ERK1/2 on threonine 202 and tyrosine 204, whereas JNK and p38 kinases were not activated. In conclusion, benfluron induces apoptosis, cell cycle arrest in late S and G2/M phases, and activates various signalling pathways of the DNA damage response.


Subject(s)
Apoptosis/drug effects , Cell Cycle Checkpoints/drug effects , Fluorenes/pharmacology , Tumor Suppressor Protein p53/metabolism , Cell Cycle/drug effects , Cell Line, Tumor , G2 Phase/drug effects , Humans , Leukemia/metabolism , Mitogen-Activated Protein Kinase 1/metabolism , Mitogen-Activated Protein Kinase 3/metabolism , Phosphorylation/drug effects , Signal Transduction/drug effects
2.
Folia Biol (Praha) ; 59(5): 188-97, 2013.
Article in English | MEDLINE | ID: mdl-24280141

ABSTRACT

Head and neck cancer is one of the most common cancers in Europe. Many current anti-cancer treatments, including ionizing radiation, induce apoptosis via DNA damage. Unfortunately, such treatments are non-selective to cancer cells and produce similar toxicity in normal cells, including adult stem cells. One of the fundamental properties of an adult stem cell is that it does not have any tissue-specific structures that allow it to perform specialized functions. However, under certain stimuli, unspecialized adult stem cells can give rise to specialized cells to generate replacements for cells that are lost during one's life or due to injury or disease. Nevertheless, specialization of stem cells must be controlled by specific milieu and also initiated at the proper time, making the entire process beneficial for tissue recovery and maintaining it for a long time. In this paper we assess whether irradiated dental pulp stem cells have maintained open their options to mature into specialized cells, or whether they have lost their unspecialized (immature) state following irradiation. Our findings showed radiation-induced premature differentiation of dental pulp stem cells towards odonto-/osteoblast lineages in vitro. Matrix calcification was visualized from Day 6 or Day 9 following irradiation of cells expressing low or high levels of CD146, respectively.


Subject(s)
Cell Differentiation/radiation effects , Cellular Senescence/radiation effects , Dental Pulp/cytology , Radiation, Ionizing , Stem Cells/cytology , Stem Cells/radiation effects , CD146 Antigen/metabolism , Cell Count , Cell Proliferation/radiation effects , Cell Survival/radiation effects , Cells, Cultured , Humans , Kinetics , Osteogenesis/radiation effects , Time Factors
3.
J Physiol Pharmacol ; 64(2): 255-66, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23756401

ABSTRACT

UNLABELLED: In this study we assessed the effects of the frequently used chemotherapeutic agent mitoxantrone (MTX) on dental pulp stem cells (DPSCs) and compared it with the response of human dermal fibroblasts (HDFs). DPSCs are valuable source of mesenchymal stem cells which may be extremely useful in a number of clinical applications. It is evident that both normal and tumor cells are being affected during therapy and characterization of these cells under genotoxic stress contributes to the evaluation of their safety usage. In the experiment cells were exposed to doses 5-150 nmol/l MTX. Proliferation of cells was detected by Z2 counter and viability by Vi-Cell XR using Trypan blue exclusion staining. Cell cycle analysis was determinated by flow cytometry, induction of apoptosis by monitoring the activities of caspases. The expression of key proteins was detected by Western blotting. Senescence was analyzed by activity of ß-galactosidase and by detection of persisting DSBs-associated γH2AX foci. Exposure of both cell types to lower concentrations of MTX resulted in premature senescence (SIPS), which was accompanied with typical morphological changes, increased activity of senescence-associated ß-galactosidase, persisting DSBs-associated γH2AX foci and cell cycle arrest in G2 phase. MTX provokes the activation of p53-p21(WAF1/Cip1) pathway in both cell types and activates cell-cycle inhibitor p16(INK4a) in HDFs, but not in DPSCs. Higher concentrations of MTX induced caspase-mediated apoptosis. CONCLUSIONS: MTX induces apoptosis or SIPS in both cell types in dependency on MTX doses. Both pathways prevent the proliferation of cells with damaged DNA.


Subject(s)
Antineoplastic Agents/pharmacology , Fibroblasts/drug effects , Mitoxantrone/pharmacology , Stem Cells/drug effects , Topoisomerase II Inhibitors/pharmacology , Apoptosis/drug effects , Caspases/metabolism , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Cells, Cultured , DNA Damage , Dental Pulp/cytology , Fibroblasts/metabolism , Humans , Male , Skin/cytology , Stem Cells/metabolism
4.
Int Endod J ; 45(5): 401-12, 2012 May.
Article in English | MEDLINE | ID: mdl-22142405

ABSTRACT

AIM: To determine the response of dental pulp stem cells (DPSCs) to DNA-damaging cytostatic cisplatin and compare it with the response of normal human dermal fibroblasts (HDFs). METHODOLOGY: Dental pulp stem cells were exposed to 5, 10, 20 or 40 µmol L(-1) of cisplatin. The proliferation of affected cells was assessed by a Z2 Counter and viability was assessed by means of a Vi-Cell XR using Trypan blue exclusion staining. Cell cycle analysis and induction of apoptosis were performed by flow cytometry. Induction of apoptosis was determined by monitoring the activities of caspases. The expression of proteins was detected by electrophoresis and Western blotting. The descriptive statistics of the results was analyzed by Student's t-test. RESULTS: Dental pulp stem cells had a greater genotoxic stress response to cisplatin compared to HDFs. All three main Mitogen-activated protein kinases (MAPK) families - extracellular signal-regulated kinases (ERK), c-Jun-N-terminal kinase (JNK) and p38 were activated after treatment of DPSCs with cisplatin. The activation of MAPK pathways was not observed in HDFs exposed to cisplatin. The exposure of DPSCs and HDFs to cisplatin provoked an increase in p53 and p21 expression and p53 phosphorylation of serine 15. Higher concentrations of cisplatin reduced the viability of DPSCs and HDFs and induced the activation of caspases 3/7 and 9. CONCLUSION: Dental pulp stem cells had a greater genotoxic stress response to cisplatin compared to HDFs. Cisplatin in higher concentrations triggered activation of MAPK and apoptosis in DPSCs but not in HDFs.


Subject(s)
Cisplatin/toxicity , Cytostatic Agents/toxicity , Dental Pulp/cytology , Ectoderm/cytology , Mesenchymal Stem Cells/drug effects , Apoptosis/drug effects , Caspase 3/drug effects , Caspase 7/drug effects , Caspase 8/drug effects , Caspase 9/drug effects , Cell Culture Techniques , Cell Cycle/drug effects , Cell Proliferation/drug effects , Cell Survival/drug effects , Cyclin-Dependent Kinase Inhibitor p21/drug effects , Dental Pulp/drug effects , Ectoderm/drug effects , Enzyme Activation/drug effects , Extracellular Signal-Regulated MAP Kinases/drug effects , Fibroblasts/drug effects , Humans , JNK Mitogen-Activated Protein Kinases/drug effects , MAP Kinase Signaling System/drug effects , Mutagens/toxicity , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Serine/drug effects , Skin/cytology , Skin/drug effects , Tumor Suppressor Protein p53/drug effects , p38 Mitogen-Activated Protein Kinases/drug effects
5.
Folia Biol (Praha) ; 57(2): 74-81, 2011.
Article in English | MEDLINE | ID: mdl-21631964

ABSTRACT

The relationship between signal pathways MEK1/2-ERK1/2 and ATM-p53 in the response to DNA damage is not well understood. The aim of our study was to investigate the effect of mitoxantrone and two protein kinase inhibitors - caffeine (inhibitor of ATM kinase) and U0126 (inhibitor of MEK1/2 kinase) - on MOLT-4 and Jurkat leukaemic cell lines. In this work we show that the inhibition of MEK1/2 is associated with an increased mortality of cells after mitoxantrone treatment. Inhibition of ATM by caffeine delayed mitoxantrone-induced cell death in MOLT-4 cells. Mitoxantrone itself induced cell-cycle arrest and accumulation of the cells in late S and G2/M phase. Inhibition of ATM, but not of MEK1/2, abrogated mitoxantrone-induced cell-cycle arrest. Inhibition of MEK1/2 did not change mitoxantroneinduced up-regulation of p53 and p21, but inhibition of ATM markedly decreased up-regulation of p53 and p21, and p53 phosphorylation on serine 15 and serine 392. It can be concluded that: 1) mitoxantrone- induced phosphorylation of p53 on serine 15 and serine 392 is ATM dependent and MEK1/2-ERK1/2 independent. 2) ATM inhibition by caffeine prevents G2 cell arrest and in p53-positive cells MOLT-4 delays the onset of mitoxantrone-induced cell death. 3) Inhibition of MEK1/2-ERK1/2 cascade potentiates the cytostatic effect of mitoxantrone regardless of the p53 status.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis , Cell Cycle Proteins/antagonists & inhibitors , DNA-Binding Proteins/antagonists & inhibitors , Mitogen-Activated Protein Kinase 1/antagonists & inhibitors , Mitogen-Activated Protein Kinase 3/antagonists & inhibitors , Mitoxantrone/pharmacology , Protein Serine-Threonine Kinases/antagonists & inhibitors , Tumor Suppressor Proteins/antagonists & inhibitors , Ataxia Telangiectasia Mutated Proteins , Butadienes/pharmacology , Cell Cycle , Cell Cycle Proteins/genetics , Cell Line, Tumor , DNA-Binding Proteins/genetics , G2 Phase/drug effects , Humans , Jurkat Cells , Mitogen-Activated Protein Kinase 3/genetics , Nitriles/pharmacology , Protein Serine-Threonine Kinases/genetics , Signal Transduction , Tumor Suppressor Proteins/genetics
6.
Physiol Res ; 60(4): 667-77, 2011.
Article in English | MEDLINE | ID: mdl-21574764

ABSTRACT

Cellular response to ionizing radiation-induced damage depends on the cell type and the ability to repair DNA damage. Some types of cells undergo apoptosis, whereas others induce a permanent cell cycle arrest and do not proliferate. Our study demonstrates two types of response of embryonic diploid fibroblasts WI-38 to ionizing radiation. In the WI-38 cells p53 is activated, protein p21 increases, but the cells are arrested in G2 phase of cell cycle. Some of the cells die by apoptosis, but in remaining viable cells p16 increases, senescence associated DNA-damage foci occur, and senescence-associated beta-galactosidase activity increases, which indicate stress-induced premature senescence.


Subject(s)
Apoptosis/radiation effects , Cellular Senescence/radiation effects , DNA Damage/radiation effects , Diploidy , Embryonic Stem Cells/radiation effects , Fibroblasts/radiation effects , Apoptosis/genetics , Cell Line , Cell Survival/genetics , Cell Survival/radiation effects , Cellular Senescence/genetics , DNA Damage/genetics , Embryonic Stem Cells/physiology , Fibroblasts/physiology , Humans , Radiation, Ionizing
SELECTION OF CITATIONS
SEARCH DETAIL
...